| Biotechnology Industry | Healthcare Sector | Mr. Jinhao Du CEO | SSE Exchange | CNE100005XJ7 ISIN |
| CN Country | 1,044 Employees | 10 Sep 2025 Last Dividend | - Last Split | - IPO Date |
Shanghai Allist Pharmaceuticals Co., Ltd. is a pioneering entity in the pharmaceutical sector, primarily based in Shanghai, China. Since its founding in 2004, the company has dedicated itself to the research and development of pharmaceutical products. Its core mission focuses on the creation of medications for the treatment of tumors and cancer diseases, addressing some of the most pressing health challenges of our time. The company's strong focus on innovation and development in the oncology sector positions it as a significant player in China's pharmaceutical industry.
Shanghai Allist Pharmaceuticals specializes in the development and provision of pharmaceutical products aimed at treating various types of tumors and cancer diseases. By leveraging advanced research methodologies and innovative practices, the company strives to create effective treatments that can improve patient outcomes and quality of life. These pharmaceuticals cover a range of cancer types, showcasing the company’s commitment to addressing the complex and diverse nature of oncological health issues.